US endocrine panel seeks review of chemicals testing

Low-dose effects from some endocrine-disrupting chemicals are real, according to a panel of US endocrine scientists, which has recommended that chemical testing protocols be "revisited" to take such effects into account. To the relief of industry observers, the panel was "not persuaded" of low-dose effects from the oestrogenic plastics intermediate bisphenol A - but the overall verdict will strengthen scrutiny of the product's potential impacts.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

30-day free trial 

Gain full access and pay nothing for the first 30 days

Sign up


Prices on request

  • Full access to for 12 months
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access